Detalhe da pesquisa
1.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Eur J Neurol
; 31(6): e16250, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549186
2.
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
Eur J Neurol
; 30(8): 2357-2364, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154406
3.
Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other's course?
J Neurovirol
; 26(6): 957-960, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32671809
4.
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 91(12): 1297-1303, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33055141
5.
Reliability and Repeatability Analysis of Indices to Measure Gait Deterioration in MS Patients during Prolonged Walking.
Sensors (Basel)
; 20(18)2020 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32899946
6.
Impact of natural menopause on multiple sclerosis: a multicentre study.
J Neurol Neurosurg Psychiatry
; 90(11): 1201-1206, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189614
7.
Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability.
Am J Hum Genet
; 92(2): 293-300, 2013 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352259
8.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Brain
; 138(Pt 11): 3275-86, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362907
9.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Mult Scler Relat Disord
; 87: 105594, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718748
10.
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study.
CNS Drugs
; 36(1): 83-96, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894339
11.
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
EBioMedicine
; 80: 104042, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35526306
12.
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study.
J Neurol
; 269(2): 933-944, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181077
13.
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
EBioMedicine
; 72: 103581, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563483
14.
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.
J Neurol
; 267(10): 3008-3020, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506391
15.
Novel mutations in DNA2 associated with myopathy and mtDNA instability.
Ann Clin Transl Neurol
; 6(9): 1893-1899, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31478350
16.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
J Neurovirol
; 18(5): 437-40, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611013
17.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
PLoS One
; 11(6): e0157721, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27348606
18.
Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up.
J Neurol Sci
; 212(1-2): 31-6, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12809996
19.
A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease.
Neurol Sci
; 29(1): 29-31, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18379737
20.
Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.
Cancer Genet Cytogenet
; 203(2): 345-7, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156257